Kedrion Biopharma Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 5,000

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 13

  • Investments
  • 7

Kedrion Biopharma General Information

Description

Manufacturer of plasma-derived products intended for the treatment of patients suffering from rare and chronic conditions. The company develops, produces and distributes human plasma-derived therapies for use in the treatment of hemophilia, immunodeficiencies and other severe debilitating conditions.

Contact Information

Website
www.kedrion.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
BPO/Outsource Services
Corporate Office
  • Loc. Ai Conti
  • Castelvecchio Pascoli
  • 55051 Barga(Lucca)
  • Italy
+39 0583 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kedrion Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kedrion Biopharma‘s full profile, request access.

Request a free trial

Kedrion Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of plasma-derived products intended for the treatment of patients suffering from rare and chronic condition
Biotechnology
Barga, Italy
5,000 As of 2023
00.00
000000000000 00.00

000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000 000000000
Lake Forest, IL
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kedrion Biopharma Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Assertio Holdings Formerly VC-backed Lake Forest, IL 00 00000 000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

Kedrion Biopharma Patents

Kedrion Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3036425-A1 Process for plasminogen purification starting from human plasma Pending 13-Sep-2016 0000000000
EP-3512940-A1 Process for plasminogen purification starting from human plasma Pending 13-Sep-2016 0000000000
AU-2017326469-A1 Process for plasminogen purification starting from human plasma Inactive 13-Sep-2016 0000000000
US-11591587-B2 Process for plasminogen purification starting from human plasma Active 13-Sep-2016 0000000000 0
US-20190330611-A1 Process for plasminogen purification starting from human plasma Active 13-Sep-2016 C12N9/6435
To view Kedrion Biopharma’s complete patent history, request access »

Kedrion Biopharma Executive Team (11)

Name Title Board Seat Contact Info
Ugo Francesco Chief Executive Officer
Akos Toth Chief Financial Officer & Accounting, Finance and Controlling Director
Massimiliano Barberis Chief Operating Officer
Peer Hansen Chief Commercial Officer & General Manager Kedrion USA
Doretta Moni Legal Affairs Director
You’re viewing 5 of 11 executive team members. Get the full list »

Kedrion Biopharma Board Members (10)

Name Representing Role Since
00000000 00000 CDP Equity Board Member 000 0000
00000 00000000 Kedrion Biopharma Co-Founder & Chairman 000 0000
00000 000000 Permira Board Member 000 0000
0000 000000 Kedrion Biopharma Board Member 000 0000
You’re viewing 4 of 10 board members. Get the full list »

Kedrion Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kedrion Biopharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kedrion Biopharma‘s full profile, request access.

Request a free trial

Kedrion Biopharma Investments (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
UNICAplasma 05-Dec-2022 0000000000 Clinics/Outpatient Services 00000 000
Bio Products Laboratory 01-Sep-2022 0000000000 Biotechnology 00000 000
Prometic Plasma Resources 21-May-2021 0000000000 0000 Other Pharmaceuticals and Biotechnology 00000 000
Entegrion 19-Mar-2014 00000 0000 000 Diagnostic Equipment
Ortho Clinical Diagnostics (RhoGam Business) 31-Jul-2012 Buyout/LBO Clinics/Outpatient Services
You’re viewing 5 of 7 investments. Get the full list »

Kedrion Biopharma Subsidiaries (3)

Company Name Industry Location Founded
Prometic Plasma Resources Other Pharmaceuticals and Biotechnology Winnipeg, Canada 2015
Bio Products Laboratory Biotechnology Elstree, United Kingdom 0000
UNICAplasma Clinics/Outpatient Services Prague, Czech Republic
To view Kedrion Biopharma’s complete subsidiaries history, request access »

Kedrion Biopharma FAQs

  • When was Kedrion Biopharma founded?

    Kedrion Biopharma was founded in 2001.

  • Who is the founder of Kedrion Biopharma?

    Paolo Marcucci is the founder of Kedrion Biopharma.

  • Who is the CEO of Kedrion Biopharma?

    Ugo Francesco is the CEO of Kedrion Biopharma.

  • Where is Kedrion Biopharma headquartered?

    Kedrion Biopharma is headquartered in Barga, Italy.

  • What is the size of Kedrion Biopharma?

    Kedrion Biopharma has 5,000 total employees.

  • What industry is Kedrion Biopharma in?

    Kedrion Biopharma’s primary industry is Biotechnology.

  • Is Kedrion Biopharma a private or public company?

    Kedrion Biopharma is a Private company.

  • What is Kedrion Biopharma’s current revenue?

    The current revenue for Kedrion Biopharma is 000000.

  • How much funding has Kedrion Biopharma raised over time?

    Kedrion Biopharma has raised $1.6B.

  • Who are Kedrion Biopharma’s investors?

    Abu Dhabi Investment Authority, Ampersand Capital Partners, Permira, FSI Funds, and CDP Equity are 5 of 6 investors who have invested in Kedrion Biopharma.

  • Who are Kedrion Biopharma’s competitors?

    Assertio Holdings is a competitor of Kedrion Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »